These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 18157141

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Molecular dynamics of human-specific cytolysin: analysis of membrane binding motif for therapeutic application.
    Ohkura K, Hori H, Nagamune H.
    Anticancer Res; 2006; 26(6A):4055-62. PubMed ID: 17195457
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Insights into the action of the superfamily of cholesterol-dependent cytolysins from studies of intermedilysin.
    Polekhina G, Giddings KS, Tweten RK, Parker MW.
    Proc Natl Acad Sci U S A; 2005 Jan 18; 102(3):600-5. PubMed ID: 15637162
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess.
    Nagamune H, Ohnishi C, Katsuura A, Fushitani K, Whiley RA, Tsuji A, Matsuda Y.
    Infect Immun; 1996 Aug 18; 64(8):3093-100. PubMed ID: 8757839
    [Abstract] [Full Text] [Related]

  • 30. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59.
    Kennedy SP, Rollins SA, Burton WV, Sims PJ, Bothwell AL, Squinto SP, Zavoico GB.
    Transplantation; 1994 May 27; 57(10):1494-501. PubMed ID: 7515200
    [Abstract] [Full Text] [Related]

  • 31. Expression and function of human CD59 and human CD55 in transgenic mice.
    Somerville C, van Denderen B, Adam B, Aminian A, Allison J, Pearse M, d'Apice A.
    Transplant Proc; 1995 Dec 27; 27(6):3565-6. PubMed ID: 8540103
    [No Abstract] [Full Text] [Related]

  • 32. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
    McCurry KR, Kooyman DL, Diamond LE, Byrne GW, Logan JS, Platt JL.
    Transplantation; 1995 Apr 27; 59(8):1177-82. PubMed ID: 7537395
    [Abstract] [Full Text] [Related]

  • 33. Structural analysis of human specific cytolysin intermedilysin aiming application to cancer immunotherapy.
    Ohkura K, Nagamune H, Kourai H.
    Anticancer Res; 2004 Apr 27; 24(5C):3343-53. PubMed ID: 15515430
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Versatile cell ablation tools and their applications to study loss of cell functions.
    Liu F, Dai S, Feng D, Peng X, Qin Z, Kearns AC, Huang W, Chen Y, Ergün S, Wang H, Rappaport J, Bryda EC, Chandrasekhar A, Aktas B, Hu H, Chang SL, Gao B, Qin X.
    Cell Mol Life Sci; 2019 Dec 27; 76(23):4725-4743. PubMed ID: 31359086
    [Abstract] [Full Text] [Related]

  • 36. CD59 is overexpressed in human lung cancer and regulates apoptosis of human lung cancer cells.
    Li B, Lin H, Fan J, Lan J, Zhong Y, Yang Y, Li H, Wang Z.
    Int J Oncol; 2013 Sep 27; 43(3):850-8. PubMed ID: 23835643
    [Abstract] [Full Text] [Related]

  • 37. Alternative roles for CD59.
    Kimberley FC, Sivasankar B, Paul Morgan B.
    Mol Immunol; 2007 Jan 27; 44(1-3):73-81. PubMed ID: 16884774
    [Abstract] [Full Text] [Related]

  • 38. LuxS and expression of virulence factors in Streptococcus intermedius.
    Pecharki D, Petersen FC, Scheie AA.
    Oral Microbiol Immunol; 2008 Feb 27; 23(1):79-83. PubMed ID: 18173802
    [Abstract] [Full Text] [Related]

  • 39. Identification of the anginosus group within the genus Streptococcus using polymerase chain reaction.
    Takao A, Nagamune H, Maeda N.
    FEMS Microbiol Lett; 2004 Apr 01; 233(1):83-9. PubMed ID: 15043873
    [Abstract] [Full Text] [Related]

  • 40. Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo.
    Schäfer A, Alp NJ, Cai S, Lygate CA, Neubauer S, Eigenthaler M, Bauersachs J, Channon KM.
    Arterioscler Thromb Vasc Biol; 2004 Sep 01; 24(9):1720-6. PubMed ID: 15242858
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.